ASML Holding NV vs Tilray Brands Inc — how do they compare? ASML Holding NV trades at $1,821.64 (market cap $689.17B), while Tilray Brands Inc trades at $4.77 (market cap $649.42M). The key difference: ASML Holding NV is far larger — about 1061.2× Tilray Brands Inc's market cap, and ASML Holding NV pays a 0.5% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| ASML | TLRY | |
|---|---|---|
Market Cap | $689.17B | $649.42M |
Sector | Technology | Health |
52-Week High | $1.99K | $21.00 |
52-Week Low | $725.85 | $3.88 |
Enterprise Value | $682.70B | $816.55M |
Dividend Yield | 0.5% | — |
Signals from Pluang's Aura AI — not financial advice
ASML trades at $1,819.44, up 4.96% today, with a bullish technical signal from moving averages. The stock shows strong fundamentals with 2025 revenue of $32.67B and net income of $9.61B, though valuation ratios like a P/E of 61.28 are elevated. Recent earnings beat expectations in Q1 and Q2 2026, and analyst consensus is a Buy with a $2,390 price target. News highlights AI-driven demand for its semiconductor equipment.
Outlook is positive due to AI lithography demand and High-NA EUV expansion, but risks include high valuation sensitivity and geopolitical threats from Chinese self-sufficiency efforts. The stock offers growth potential with 31% upside to the consensus target, balanced by execution and competitive risks.
TLRY trades at $4.71, up 6.56% today, with a bullish technical signal from moving averages but mixed oscillators. Revenue grew to $821M in 2025, yet the company posted a net loss of -$2.19B, reflecting profitability challenges. Recent news highlights growth initiatives, including a partnership with Wolverhampton Wanderers and a new THC pouch launch. The stock remains volatile, with a low P/S of 0.58 and P/B of 0.4, suggesting potential undervaluation amid ongoing losses.
Outlook is cautious; TLRY's path to profitability hinges on revenue growth and cost management. Risks include persistent losses, high debt, and regulatory uncertainty. Analyst consensus is mixed, with 25% buy ratings but 65% hold, indicating skepticism. Investors should weigh growth potential against financial instability and market volatility.
Trailing returns across standard periods
Latest headlines on both assets
Founded in 1984 and based in the Netherlands, ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photomask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a meaningful portion of the cost of making cutting-edge chips. Chipmakers require next-generation EUV lithography tools from ASML to continue past the 5-nanometer process node. ASML's products are used at every major semiconductor manufacturer, including Intel, Samsung, and TSMC.
Read more on ASML →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →